A-01
Registration at the conference venue
Tuesday 14:00-18:00 |
A-02
Opening ceremony, welcome reception and dinner
Tuesday 19:00-22:00 |
B-01
Registration at the conference venue
Wednesday 08:00-08:45 |
B-02
Welcome and Introduction
Wednesday 08:45-09:00 |
B-03 Praveen Thokala
Overview and implementation of multi criteria decision analysis (MCDA) for benefit-risk assessment
Wednesday 09:00-09:30 |
B-04 Andreas Kouroumalis
European regulatory views on benefit-risk assessment methodologies - role of MCDA and other model-based approaches
Wednesday 09:30-10:00 |
B-05 Kevin Marsh
Current practices and gaps in benefit-risk assessment: opportunities for combining MCDA with model-based approaches
Wednesday 10:00-10:30 |
B-06
Coffee break, poster and software session I: posters in Group I (with poster numbers starting with I-) are accompanied by their presenter
Wednesday 10:30-12:00 |
B-07 Neeraj Gupta
Model-Informed Drug Development (MIDD) for ixazomib, an oral proteasome inhibitor
Wednesday 12:00-12:20 |
B-08 Nadia Terranova
Simulation analysis of absolute lymphocytes counts (ALC) and relapse rate (RR) following cladribine (re-)treatment rules in subjects with relapsing-remitting multiple sclerosis (RRMS)
Wednesday 12:20-12:40 |
B-09
Announcement of ACoP8
Wednesday 12:40-12:45 |
B-10
Lunch
Wednesday 12:45-14:10 |
B-11 Joe Standing
Scaling pharmacodynamics in children: Lessons from immunology, infectious diseases and critical care
Wednesday 14:10-14:50 |
B-12 Nick Holford
Scaling renal function in neonates and infants to describe the pharmacodynamics of antibiotic nephrotoxicity
Wednesday 14:50-15:10 |
B-13
Tea break, poster and software session II: posters in Group II (with poster numbers starting with II-) are accompanied by their presenter
Wednesday 15:10-16:40 |
B-14 Hanna Silber Baumann
Using pharmacokinetic simulation to guide dose escalation decisions for targeted IL2v immunocytokines
Wednesday 16:40-17:00 |
B-15 Simon Buatois
Modelling approaches in dose finding clinical trial: Simulation-based study comparing predictive performances of model averaging and model selection.
Wednesday 17:00-17:20 |
B-16 Yuri Kheifetz
Model-based individual managing of thrombocytopenia during multi-cyclic chemotherapy
Wednesday 17:20-17:40 |
B-17 Jurgen Langenhorst
High exposure to fludarabine in conditioning prior to allogeneic hematopoietic cell transplantation predicts impaired CD4 reconstitution and lower probability of survival
Wednesday 17:40-18:00 |
C-01 Elisa Borella
Paediatric trial design optimization using prior knowledge in combination with modelling & simulations
Thursday 08:30-08:55 |
C-02 John Diep
Host-Pathogen interactions: A mechanism-based disease progression model to describe the pathogenesis of Acinetobacter baumannii pneumonia
Thursday 08:55-09:20 |
C-03 Morris Muliaditan
Model-based rationale for drug combinations in tuberculosis
Thursday 09:20-09:45 |
C-04
Presentation of Lewis Sheiner student session awards
Thursday 09:45-09:50 |
C-05
Coffee break, poster and software session III: posters in Group III (with poster numbers starting with III-) are accompanied by their presenter
Thursday 09:50-11:20 |
C-06 Robert Leary
An overview of non-parametric estimation methods used in population analysis
Thursday 11:20-12:00 |
C-07 Mats Karlsson
A comparison of performance between parametric and nonparametric estimation for nonlinear mixed-effects models
Thursday 12:00-12:20 |
C-08
Announcement for WCoP 2020
Thursday 12:20-12:25 |
C-09
Lunch
Thursday 12:25-13:40 |
C-11 Kristin Karlsson
Regulatory pharmacometrics in the EU in practice and the role of the Modelling and Simulation Working Group
Thursday 13:45-14:15 |
C-12 Anna Nordmark
The new draft EMA Guidance on PBPK – The qualification of the intended use concept
Thursday 14:15-14:45 |
C-13
Tea break, poster and software session IV: posters in Group IV (with poster numbers starting with IV-) are accompanied by their presenter
Thursday 14:45-16:15 |
C-14
In memoriam Matt Hutmacher
Thursday 16:15-16:20 |
C-15 Wojciech Krzyzanski
Correction of the likelihood function as an alternative for imputing missing covariates
Thursday 16:20-16:40 |
C-16 Henrik Bjugård Nyberg
SADDLE_RESET: more robust parameter estimation with a check for local practical identifiability
Thursday 16:40-17:00 |
C-17 Dmitry Onishchenko
Joint modeling of overall survival and tumor size dynamics in non-small cell lung cancer: Clinical trial simulations and validation of predictions at study and subject levels
Thursday 17:00-17:20 |
C-18 Eva Germovsek
Handling frequent observations of composite scores: Application to PROs in COPD
Thursday 17:20-17:40 |
C-19
Social event
|
D-01 Markus Krauß
Translational systems pharmacology for acquisition of knowledge and prediction of drug pharmacokinetics across patient populations
Friday 09:00-09:20 |
D-02 Robin Michelet
PBPK modeling of propofol using the middle out approach
Friday 09:20-09:40 |
D-03 Miro Eigenmann
Therapeutic antibody concentrations at the biophase
Friday 09:40-10:00 |
D-04 Alan Maloney
The 6 biggest pharmacometrics modelling mistakes!
Friday 10:00-10:25 |
D-05
Preview of PAGE2018
Friday 10:25-10:30 |
D-06
Coffee break
Friday 10:30-11:15 |
D-07 Richard Höglund
Pharmacokinetic-pharmacodynamic modelling of artesunate in patients with drug resistant and sensitive malaria
Friday 11:15-11:35 |
D-08 Salvatore D'Agate
Model-based screening of compounds for the treatment of Chagas disease, a neglected tropical disease.
Friday 11:35-11:55 |
D-09 Carolina Llanos-Paez
Balancing efficacy and reduction in renal function to optimize initial gentamicin dosing in children with cancer
Friday 11:55-12:15 |
D-10
Closing remarks
Friday 12:15-12:25 |
D-11
Audience input for potential PAGE2018 topics
Friday 12:25-12:40 |
